Treatment of idiopathic Parkinson's disease: an update

被引:0
|
作者
Kang, Suk Yun [1 ]
Sohn, Young Ho
Kim, Jin-Soo
机构
[1] Yonsei Univ, Coll Med, Dept Neurol, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Brain Res Inst, Seoul 120752, South Korea
关键词
Parkinsons disease; dopamine; levodopa; late complication; surgery;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Since 196 1, levodopa has been the most effective treatment for idiopathic Parkinson's disease (PD). However, its long-term use often causes late complications including response fluctuations and abnormal involuntary movements. As merely a symptomatic treatment, this drug does not prevent the disease progression. With advent of new drugs, several approaches have attempted either to delay the disease progression or to prevent the late complications related to levodopa therapy. In addition, the new surgical techniques such as fetal dopaminergic cell transplantation and deep brain stimulation (DBS) have shown some promising results. Here we review the most recent information on treatment of PD to show the new trends for the effective therapeutic strategies. We also briefly discuss the possible new therapy in the future.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 50 条
  • [1] An update on the treatment of Parkinson's disease
    Jankovic, Joseph
    [J]. MOUNT SINAI JOURNAL OF MEDICINE, 2006, 73 (04): : 682 - 689
  • [2] Update on Diagnostics and Therapy of idiopathic Parkinson's Disease (Reprinted)
    Waldthaler, Josefine
    Timmermann, Lars
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2019, 87 (08) : 445 - 459
  • [3] Update on idiopathic Parkinson's syndrome: which treatment is best?
    Reichmann, H.
    [J]. NERVENHEILKUNDE, 2009, 28 (11) : 797 - 800
  • [4] Medicinal treatment of idiopathic Parkinson's disease
    Klockgether, T
    [J]. NERVENARZT, 2003, 74 : S12 - S21
  • [5] Probiotics and the Treatment of Parkinson's Disease: An Update
    Hamed Mirzaei
    Saman Sedighi
    Ebrahim Kouchaki
    Erfaneh Barati
    Ehsan Dadgostar
    Michael Aschner
    Omid Reza Tamtaji
    [J]. Cellular and Molecular Neurobiology, 2022, 42 : 2449 - 2457
  • [6] Rasagiline for the treatment of Parkinson's disease: an update
    Stocchi, Fabrizio
    Fossati, Chiara
    Torti, Margherita
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (14) : 2231 - 2241
  • [7] Probiotics and the Treatment of Parkinson's Disease: An Update
    Mirzaei, Hamed
    Sedighi, Saman
    Kouchaki, Ebrahim
    Barati, Erfaneh
    Dadgostar, Ehsan
    Aschner, Michael
    Tamtaji, Omid Reza
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2022, 42 (08) : 2449 - 2457
  • [8] Parkinson's disease: an update on pathogenesis and treatment
    Foltynie, Tom
    Kahan, Joshua
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 (05) : 1433 - 1440
  • [9] Update on ropinirole in the treatment of Parkinson's disease
    Shill, Holly A.
    Stacy, Mark
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 33 - 36
  • [10] Initial Treatment of Parkinson’s Disease: An Update
    Scott Kaplan
    Daniel Tarsy
    [J]. Current Treatment Options in Neurology, 2013, 15 : 377 - 384